Biotech by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Biogen has the lowest figure of the 19 biotech ranked by P/S ratio, at 3.8, followed by Qiagen (4.9) and Neurocrine Biosciences (5.9). Figures as of 18 Nov 2026, 14:43 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
Lowest
Biogen3.8
Median
14.5
Combined market value
SEK 8.62T
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

Biotech by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care3.8SEK 378.3BSEK 2,559.07 0.41% up 49% up United States
2QiagenQGEN · Health Care4.9SEK 104.3BSEK 505.27 0.06% down 12% up Netherlands
3Neurocrine BiosciencesNBIX · Health Care5.9SEK 170.3BSEK 1,682.87 0.19% down 20% up United States
4BioNTechBNTX · Health Care6.6SEK 214.4BSEK 864.96 0.30% up 16% down Germany
5AmgenAMGN · Health Care6.7SEK 2.49TSEK 4,602.29 1.10% down 34% up United States
6Gilead SciencesGILD · Health Care7.1SEK 2.14TSEK 1,724.34 0.34% down 33% up United States
7ExelixisEXEL · Health Care7.2SEK 170BSEK 696.88 0.11% up 63% up United States
8Halozyme TherapeuticsHALO · Health Care7.9SEK 111.5BSEK 977.87 0.27% up 37% up United States
9Bio-TechneTECH · Health Care9.4SEK 116.1BSEK 739.05 0.13% up 26% up United States
10argenxARGX · Health Care14.5SEK 613.6BSEK 9,757.72 1.34% up 4% up Belgium
11RepligenRGEN · Health Care14.7SEK 110.5BSEK 1,728.45 4.87% up 5% up United States
12Adaptive BiotechnologiesADPT · Health Care16.8SEK 47.3BSEK 292.27 0.95% up 88% up United States
13Twist BioscienceTWST · Health Care20.5SEK 78.5BSEK 1,151.59 1.18% up 340% up United States
14Krystal BiotechKRYS · Health Care23.0SEK 91.1BSEK 3,073.58 1.31% up 46% up United States
15ModernaMRNA · Health Care43.2SEK 852.9BSEK 2,107.86 0.30% up 755% up United States
16ImmunityBioIBRX · Health Care58.4SEK 67.2BSEK 63.21 0.64% down 193% up United States
17Kymera TherapeuticsKYMR · Health Care267SEK 106.5BSEK 1,247.62 1.03% up 87% up United States
18CRISPR TherapeuticsCRSP · Health Care1161SEK 41.4BSEK 426.79 4.60% up 21% down Switzerland
19CG OncologyCGON · Health Care1755SEK 72.1BSEK 806.68 0.56% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1623 SEK). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech have the lowest P/S ratio?

Biogen (3.8), Qiagen (4.9) and Neurocrine Biosciences (5.9) have the lowest P/S ratio of the 19 biotech ranked here as of 18 Nov 2026, 14:43 UTC.

How many biotech are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 19 biotech ranked by P/S ratio have a combined market value of SEK 8.62T as of 18 Nov 2026, 14:43 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.